CGEM Cullinan Therapeutics

• None no insider bought on the open market
• None no sales outside a trading plan
• $1.5M sold by 1 insider under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Jennifer Michaelson Chief Scientific Officer
   Planned sale
   $173K 8,000 shares at $21.57 4.8% of stake
   Traded Sep 8 Filed Sep 10
   ↗
3. Jennifer Michaelson Chief Scientific Officer
   Planned sale
   $608K 30,000 shares at $20.26 16% of stake
   Traded Aug 13 Filed Aug 14
   ↗
4. Jennifer Michaelson Chief Scientific Officer
   Planned sale
   $143K 8,000 shares at $17.82 4.7% of stake
   Traded Jul 6 Filed Jul 7
   ↗
5. Jennifer Michaelson Chief Scientific Officer
   Planned sale
   $117K 8,000 shares at $14.62 4.6% of stake
   Traded May 5 Filed May 6
   ↗
6. Jennifer Michaelson Chief Scientific Officer
   Planned sale
   $125K 8,000 shares at $15.68 4.5% of stake
   Traded Mar 5 Filed Mar 9
   ↗
7. Jennifer Michaelson Chief Scientific Officer
   Planned sale
   $25K 1,780 shares at $14.14 1% of stake
   Traded Feb 25 Filed Feb 26
   ↗
8. Jennifer Michaelson Chief Scientific Officer
   Planned sale
   $25K 1,752 shares at $13.99 1% of stake
   Traded Feb 23 Filed Feb 25
   ↗
9. Jennifer Michaelson Chief Scientific Officer
   Planned sale
   $114K 8,000 shares at $14.30 4.2% of stake
   Traded Feb 20 Filed Feb 23
   ↗
10. Jennifer Michaelson Chief Scientific Officer
    Planned sale
    $49K 4,000 shares at $12.30 3% of stake
    Traded Jan 22 Filed Jan 23
    ↗
11. Jennifer Michaelson Chief Scientific Officer
    Planned sale
    $13K 1,345 shares at $10.01 1% of stake
    Traded Dec 19, 2025 Filed Dec 22, 2025
    ↗
12. Jennifer Michaelson Chief Scientific Officer
    Planned sale
    $12K 995 shares at $11.90 0.7% of stake
    Traded Dec 15, 2025 Filed Dec 16, 2025
    ↗
13. Jennifer Michaelson Chief Scientific Officer
    Planned sale
    $49K 4,000 shares at $12.30 2.8% of stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
    ↗
14. Lynx1 Capital Management LP 10% owner, +1 joint filer
    Buy
    $1.4M 165,667 shares at $8.40 +1.9% to stake
    Traded Oct 28, 2025 Filed Oct 30, 2025
    ↗
15. Lynx1 Capital Management LP 10% owner, +1 joint filer
    Buy
    $2.1M 248,749 shares at $8.46
    Traded Oct 14–17 Filed Oct 21, 2025
    ↗
16. Lynx1 Capital Management LP 10% owner, +1 joint filer
    Buy
    $9.8M 1,459,641 shares at $6.73
    Traded Oct 8–10 Filed Oct 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 15 sales to cover taxes, 6 option exercises, and 5 stock grants.